In the News
Neurala closes $14M Series A to bring machine learning to the edge, TechCrunch.
“Massimiliano Versace, CEO of Neurala (yes, of relation to the fashion house Versace) says the team is looking to put AI in the hands of toy makers, drone enthusiasts and IoT engineers alike.”
eGenesis. CRISPR Organs? eGenesis Raises $38M For Pig-To-Human Transplants, Xconomy.
“Spun out of Harvard University in 2014 to the VDC—one of the firm’s cofounders is Harvard’s George Church, a leading geneticist—eGenesis wants to increase the supply of organs for desperate patients. Soon after its launch, eGenesis made a big splash with a paper in the journal Science.”
BlueFever. Blue Fever Streaming Platform Launched to Transcend Hollywood Sexism, Diverge.
“There are 850 million millennial women worldwide who are hungry for incredible entertainment made for them,” says CEO Lauren Tracy.
Ori Systems. Robo-Furniture From MIT Makes The Most of Tiny Apartments, WIRED.
“Surely you’ve heard that by 2050, two-thirds of the world’s population will live in cities?,” says founder, Hasier Larrea.
Humon. Measuring oxygen levels is the fitness metric everyone is going to want, Wearable.
“I was at MIT Sloan and became very obsessed that biology and technology would intersect and help you learn more about your body,” says Humon’s co-founder Alessandro Babini.
SQZ Biotech. Boston biotech startup SQZ seals a $500M deal with drug giant Roche, Boston Business Journal.
“The deal with Roche is one that would be transformative for most of the areas’ larger, publicly-traded biotech firms.”
ConquerX. This CEO has a promising startup but no visa, MedCityNews.
“Deborah Zanforlin has journeyed through some of the top U.S. incubator programs. What she didn’t have is a U.S. visa. Then, she earned a spot as a Global Entrepreneur-In-Residence at the VDC, which comes with an H1-B visa.”
George Church startup engineers novel and improved microbes.